These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12547502)

  • 21. The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts.
    Kaseke C; Tano-Menka R; Senjobe F; Gaiha GD
    J Infect Dis; 2021 Feb; 223(12 Suppl 2):32-37. PubMed ID: 33586771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
    Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
    J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of HIV-1 replication by HIV-1-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-1-infected cells in vitro.
    Liu H; Ohashi T; Masuda T; Zhou X; Kubo M; Kannagi M
    Viral Immunol; 2003; 16(3):381-93. PubMed ID: 14583152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of prophylactic AIDS vaccines: the current state of affairs.
    Hanke T
    Curr Opin Mol Ther; 2003 Feb; 5(1):25-32. PubMed ID: 12669467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
    Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An algorithm for evaluating human cytotoxic T lymphocyte responses to candidate AIDS vaccines.
    Carruth LM; Greten TF; Murray CE; Castro MG; Crone SN; Pavlat W; Schneck JP; Siliciano RF
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):1021-34. PubMed ID: 10445814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques.
    Paliard X; Liu Y; Wagner R; Wolf H; Baenziger J; Walker CM
    AIDS Res Hum Retroviruses; 2000 Feb; 16(3):273-82. PubMed ID: 10710215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 vaccination administered intramuscularly can induce both systemic and mucosal T cell immunity in HIV-1-uninfected individuals.
    Musey L; Ding Y; Elizaga M; Ha R; Celum C; McElrath MJ
    J Immunol; 2003 Jul; 171(2):1094-101. PubMed ID: 12847284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccines and vaccine strategies against HIV.
    Stratov I; DeRose R; Purcell DF; Kent SJ
    Curr Drug Targets; 2004 Jan; 5(1):71-88. PubMed ID: 14738219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group.
    Corey L; McElrath MJ; Weinhold K; Matthews T; Stablein D; Graham B; Keefer M; Schwartz D; Gorse G
    J Infect Dis; 1998 Feb; 177(2):301-9. PubMed ID: 9466515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
    Barouch DH; Santra S; Schmitz JE; Kuroda MJ; Fu TM; Wagner W; Bilska M; Craiu A; Zheng XX; Krivulka GR; Beaudry K; Lifton MA; Nickerson CE; Trigona WL; Punt K; Freed DC; Guan L; Dubey S; Casimiro D; Simon A; Davies ME; Chastain M; Strom TB; Gelman RS; Montefiori DC; Lewis MG; Emini EA; Shiver JW; Letvin NL
    Science; 2000 Oct; 290(5491):486-92. PubMed ID: 11039923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV: current opinion in escapology.
    Klenerman P; Wu Y; Phillips R
    Curr Opin Microbiol; 2002 Aug; 5(4):408-13. PubMed ID: 12160861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of preimmunization virus sequences in cellular immunity in HIV-infected patients during HIV type 1 MN recombinant gp160 immunization.
    Kundu SK; Dupuis M; Sette A; Celis E; Dorner F; Eibl M; Merigan TC
    AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1669-78. PubMed ID: 9870321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [[Research Progress in Escape Mutations of the Human Immunodeficiency Virus under Pressure of HLA-Restricted Cytotoxic T Lymphocytes].
    Shi Y; Wan Y; Xu J
    Bing Du Xue Bao; 2015 May; 31(3):299-306. PubMed ID: 26470538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.
    Belyakov IM; Ahlers JD
    Curr Top Microbiol Immunol; 2012; 354():157-79. PubMed ID: 21203884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination with CTL epitopes that escape: an alternative approach to HIV vaccine development?
    O'Connor D; Allen T; Watkins DI
    Immunol Lett; 2001 Nov; 79(1-2):77-84. PubMed ID: 11595292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 adaptation to HLA: a window into virus-host immune interactions.
    Carlson JM; Le AQ; Shahid A; Brumme ZL
    Trends Microbiol; 2015 Apr; 23(4):212-24. PubMed ID: 25613992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress towards an AIDS mucosal vaccine: an overview.
    Yuki Y; Nochi T; Kiyono H
    Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S35-44. PubMed ID: 17652028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.